Drug Trial Radar · NCT00280657
Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa
Last checked: Nov 20, 2026Latest source record: Jun 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,326
Actual
Start
Mar 10, 2004
Primary completion
May 21, 2005
Study completion May 21, 2005
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Jan 23, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- Female only, from 16 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to determine safety and efficacy of an oral contraceptive in treating acne papulopustulosa.
Conditions
- Acne Vulgaris
Interventions
ValetteDrug
1 tablet 0.030 mg ethinylestradiol / 2 mg dienogest + 1 placebo tablet daily for 21 days followed by a 7-day tablet-free interval, oral administration for 6 cycles
DianeDrug
1 tablet 0.035 mg ethinylestradiol / 2 mg cyproterone acetate + 1 placebo tablet daily for 21 days followed by a 7-day tablet-free interval, oral administration for 6 cycles
PlaceboDrug
2 placebo tablets daily for 21 days followed by a 7-day tablet-free interval, oral administration for 6 cycles
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in lesionsTime frame: 6 months
Locations
62 sites in 5 countries. Site status is shown where the registry gives one.
Site not named
Čáslav, Czechia
Site not named
Chomutov, Czechia
Site not named
Kutná Hora, Czechia
Site not named
Louny, Czechia
Site not named
Olomouc, Czechia
Site not named
Prague, Czechia
Site not named
Prague, Czechia
Site not named
Slaný, Czechia
Site not named
Svitavy, Czechia
Site not named
Ústí nad Labem, Czechia
Site not named
Grudziądz, Poland
Site not named
Lodz, Poland
Site not named
Lublin, Poland
Site not named
Poznan, Poland
Site not named
Warsaw, Poland
Site not named
Warsaw, Poland
Site not named
Warsaw, Poland
Site not named
Warsaw, Poland
Site not named
Wroclaw, Poland
Site not named
Korolyov, Russia
Site not named
Moscow, Russia
Site not named
Moscow, Russia
Site not named
Moscow, Russia
Site not named
Moscow, Russia
Site not named
Moscow, Russia
Site not named
Moscow, Russia
Site not named
Moskva, Russia
Site not named
Moskva, Russia
Site not named
Petrozavodsk, Russia
Site not named
Saint Petersburg, Russia
Site not named
Saint Petersburg, Russia
Site not named
Saint Petersburg, Russia
Site not named
Saint Petersburg, Russia
Site not named
Saint Petersburg, Russia
Site not named
Saint Petersburg, Russia
Site not named
Saint Petersburg, Russia
Site not named
Saint Petersburg, Russia
Site not named
Saint Petersburg, Russia
Site not named
Banská Bystrica, Slovakia
Site not named
Bratislava, Slovakia
Showing 40 of 62 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.